Dr. Michael Vincent Tablang, M.D.
What this data tells you about Dr. Tablang
Dr. Michael Vincent Tablang is an infectious disease in Crestview, FL, with 18 years in practice. Based on federal Medicare data, Dr. Tablang performed 716,905 Medicare services across 3,284 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tablang received a total of $3,453 from 27 pharmaceutical and/or device companies across 178 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tablang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 566,961 | $0 | $0 |
| Injection, omadacycline, 1 mg | 103,601 | $3 | $8 |
| Injection, oritavancin (kimyrsa), 10 mg | 23,880 | $32 | $109 |
| Injection, dalbavancin, 5 mg | 3,600 | $12 | $42 |
| Injection, cefepime hydrochloride, 500 mg | 2,523 | $1 | $4 |
| Ceftriaxone antibiotic injection | 2,503 | $0 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 2,092 | $48 | $177 |
| Office visit, established patient (30-39 min) | 1,843 | $98 | $352 |
| Injection, ertapenem sodium, 500 mg | 1,808 | $11 | $63 |
| Hospital follow-up visit, high complexity | 1,714 | $93 | $333 |
| Denosumab injection (Prolia/Xgeva) | 1,200 | $19 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,080 | $22 | $83 |
| Critical care, first 30-74 min | 836 | $168 | $509 |
| Removal of skin and tissue, 20.0 sq cm or less | 778 | $99 | $362 |
| Hospital follow-up visit, moderate complexity | 514 | $62 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 484 | $15 | $55 |
| Initial hospital admission, high complexity | 401 | $136 | $490 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 204 | $17 | $42 |
| Application of vein wound compression bandages on lower leg, ankle, and foot | 181 | $67 | $289 |
| New patient office visit (45-59 min) | 150 | $128 | $473 |
| Removal of tissue from wound, 20.0 sq cm or less | 149 | $76 | $231 |
| Anti-nausea injection (ondansetron/Zofran) | 82 | $0 | $0 |
| Removal of skin and tissue, each additional 20.0 sq cm or less | 63 | $32 | $114 |
| Strapping, unna boot | 63 | $52 | $236 |
| Office visit, established patient (20-29 min) | 48 | $69 | $270 |
| Drug injection, under skin or into muscle | 44 | $11 | $37 |
| New patient office visit, complex (60-74 min) | 34 | $120 | $474 |
| Injection of additional new drug or substance into vein | 31 | $12 | $51 |
| Office visit, established patient, complex (40-54 min) | 22 | $121 | $428 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $40 | $156 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tablang is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tablang experienced with daptomycin antibiotic injection?
Does Dr. Tablang receive payments from pharmaceutical companies?
How do Dr. Tablang's costs compare to other infectious diseases in Crestview?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology